C

Castle Creek Biosciences, Inc.

35 employees

Castle Creek Biosciences is focused on developing commercializing novel, personalized gene therapies for rare skin disorders.

Basic info

Industry

biotechnology research

Sectors

Pharmaceutical
Biotechnology
Pediatric disease
Life Science
Localized Scleroderma
Epidermolysis Bullosa
Personalized medicine
Bioscience
Biopharma
Orphan drug
Clinical research
Rare disease
Life sciences
Dermatology
Gene therapy
Genetics
Drug development

Date founded

2020

Funding rounds raised

Total raised

$113M

from 6 investors over 6 rounds

C

Castle Creek Biosciences, Inc. raised $113M on May 2, 2022

Investors: Paragon Biosciences and Valor Equity Partners

C

Castle Creek Biosciences, Inc. raised $20M on March 25, 2020

Investors: Horizon Technology Finance

C

Castle Creek Biosciences, Inc. raised $55M on March 25, 2020

Investors: Valor Equity Partners and Paragon Biosciences

C

Castle Creek Biosciences, Inc. raised $72M on October 19, 2018

Investors: Valor Equity Partners

FAQ